These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myasthenia gravis in childhood. Anlar B; Ozdirim E; Renda Y; Yalaz K; Aysun S; Topçu M; Topaloğlu H Acta Paediatr; 1996 Jul; 85(7):838-42. PubMed ID: 8819551 [TBL] [Abstract][Full Text] [Related]
4. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis. Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and evolution of juvenile myasthenia gravis in a French cohort. Barraud C; Desguerre I; Barnerias C; Gitiaux C; Boulay C; Chabrol B Muscle Nerve; 2018 Apr; 57(4):603-609. PubMed ID: 28877546 [TBL] [Abstract][Full Text] [Related]
6. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy. Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058 [TBL] [Abstract][Full Text] [Related]
9. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Andrews PI; Massey JM; Howard JF; Sanders DB Neurology; 1994 Jul; 44(7):1208-14. PubMed ID: 8035917 [TBL] [Abstract][Full Text] [Related]
10. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis. Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921 [TBL] [Abstract][Full Text] [Related]
11. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study. Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL; BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795 [TBL] [Abstract][Full Text] [Related]
12. Juvenile Myasthenia Gravis in North Texas: Clinical Features, Treatment Response, and Outcomes. Lu M; Reisch J; Iannaccone S; Batley K Pediatr Neurol; 2024 Jul; 156():10-14. PubMed ID: 38688232 [TBL] [Abstract][Full Text] [Related]
13. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays. Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216 [TBL] [Abstract][Full Text] [Related]
15. Factors affecting outcome in ocular myasthenia gravis. Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092 [TBL] [Abstract][Full Text] [Related]
16. Comparison of juvenile and adult myasthenia gravis in a French cohort with focus on thymic histology. Truffault F; Auger L; Dragin N; Vilquin JT; Fadel E; Thomas de Montpreville V; Mansuet-Lupo A; Regnard JF; Alifano M; Sharshar T; Behin A; Eymard B; Bolgert F; Demeret S; Berrih-Aknin S; Le Panse R Sci Rep; 2024 Jun; 14(1):13955. PubMed ID: 38886398 [TBL] [Abstract][Full Text] [Related]
17. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis. Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131 [TBL] [Abstract][Full Text] [Related]
18. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China. Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131 [TBL] [Abstract][Full Text] [Related]